Apellis Stock Future Price Prediction

APLS -  USA Stock  

USD 44.81  0.33  0.74%

Apellis Pharmaceuticals stock price prediction is an act of determining the future value of Apellis Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Apellis Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Apellis Pharmaceuticals and does not consider all of the tangible or intangible factors available from Apellis Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Apellis Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Please continue to Apellis Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Apellis Pharmaceuticals based on different types of headlines from major news networks to social media. The Apellis stock price prediction module provides an analysis of price elasticity to changes in media outlook on Apellis Pharmaceuticals over a specific investment horizon. Using Apellis Pharmaceuticals hype-based prediction, you can estimate the value of Apellis Pharmaceuticals from the perspective of Apellis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Apellis Pharmaceuticals using Apellis Pharmaceuticals' options and short interest. It helps to benchmark the overall future attitude of investors towards Apellis using crowd psychology based on the activity and movement of Apellis Pharmaceuticals' stock price.
Apellis Pharmaceuticals Book Value per Share is relatively stable at the moment as compared to the past year. Apellis Pharmaceuticals reported last year Book Value per Share of 2.35. As of 05/20/2022, Current Ratio is likely to grow to 7.99, while Earnings per Basic Share are likely to drop (9.07) .

Apellis Pharmaceuticals Implied Volatility

Apellis Pharmaceuticals' implied volatility exposes the market's sentiment of Apellis Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Apellis Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Apellis Pharmaceuticals stock will not fluctuate a lot when Apellis Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Apellis Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Apellis Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Apellis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Apellis Pharmaceuticals after-hype prediction price

  $ 44.82  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Apellis Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Apellis Pharmaceuticals in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
13 Analysts
LowTarget PriceHigh
Estimates (9)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Apellis Pharmaceuticals. Your research has to be compared to or analyzed against Apellis Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Apellis Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Apellis Pharmaceuticals.

Apellis Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Apellis Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Apellis Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Apellis Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Apellis Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Apellis Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Apellis Pharmaceuticals' historical news coverage. Apellis Pharmaceuticals' after-hype downside and upside margins for the prediction period are 40.02 and 49.62, respectively. We have considered Apellis Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 44.81
After-hype Price
Apellis Pharmaceuticals is very steady asset. Analysis and calculation of next after-hype price of Apellis Pharmaceuticals is based on 3 months time horizon.

Apellis Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Apellis Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Apellis Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Apellis Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.15  4.80  0.01   0.03  8 Events / Month1 Events / MonthIn about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Apellis Pharmaceuticals Hype Timeline

Apellis Pharmaceuticals is presently traded for 44.81. The entity has historical hype elasticity of 0.01 and average elasticity to hype of competition of 0.03. Apellis is expected to increase in value after the next headline with price projected to jump to 44.82 or above. The average volatility of media hype impact on the company stock price is over 100%. The price gain on the next news is forecasted to be 0.02% whereas the daily expected return is presently at 0.15%. The volatility of related hype on Apellis Pharmaceuticals is about 2526.32% with expected price after next announcement by competition of 44.84. The company reported the previous year's revenue of 256.27 M. Net Loss for the year was (520.16 M) with loss before overhead, payroll, taxes, and interest of (74.33 M). Given the investment horizon of 90 days the next expectedpress releasewill be in about 8 days.
Please continue to Apellis Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Apellis Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Apellis Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Apellis Pharmaceuticals' future price movements. Getting to know how Apellis Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Apellis Pharmaceuticals may potentially react to the hype associated with one of its peers.

Apellis Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Apellis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Apellis using various technical indicators. When you analyze Apellis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Apellis Pharmaceuticals Predictive Indicators

The successful prediction of Apellis Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Apellis Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Apellis Pharmaceuticals based on analysis of Apellis Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Apellis Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Apellis Pharmaceuticals's related companies.
 2021 2022 (projected)
Book Value per Share2.352.93
Asset Turnover0.0910.13

Story Coverage note for Apellis Pharmaceuticals

The number of cover stories for Apellis Pharmaceuticals depends on current market conditions and Apellis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Apellis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Apellis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Apellis Pharmaceuticals Short Properties

Apellis Pharmaceuticals' future price predictability will typically decrease when Apellis Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Apellis Pharmaceuticals often depends not only on the future outlook of the potential Apellis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Apellis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out7.41%
Short Percent Of Float10.22%
Float Shares68.42M
Shares Short Prior Month5.89M
Average Daily Volume Last 10 Day1.29M
Average Daily Volume In Three Month1.2M
Date Short Interest15th of December 2021
Please continue to Apellis Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Note that the Apellis Pharmaceuticals information on this page should be used as a complementary analysis to other Apellis Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Apellis Stock analysis

When running Apellis Pharmaceuticals price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Apellis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apellis Pharmaceuticals. If investors know Apellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apellis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Apellis Pharmaceuticals is measured differently than its book value, which is the value of Apellis that is recorded on the company's balance sheet. Investors also form their own opinion of Apellis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Apellis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apellis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Apellis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apellis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Apellis Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apellis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.